Example ImageÃÀ¸ß÷

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Customer Center
¿Í»§ÖÐÐÄ

ŵ»ª»ùÒòÖÎÁÆÒ©ÎïÔÚÖйúÄâÄÉÈëÓÅÏÈÉóÆÀ | 1·ÖÖÓÒ©ÎÅËÙÀÀ

2025-07-16
|
»á¼ûÁ¿£º

17.jpgÒ½ÏßÒ©ÎÅ

1. 7ÔÂ16ÈÕ£¬£¬£¬£¬£¬CDE¹«Ê¾£¬£¬£¬£¬£¬Åµ»ª£¨Novartis£©É걨µÄonasemnogene abeparvovecÇÊÄÚ×¢ÉäÒº£¨OAV101×¢ÉäÒº£©ÄâÄÉÈëÓÅÏÈÉóÆÀ£¬£¬£¬£¬£¬ÕâÊÇÒ»ÖÖ»ùÓÚÏÙÏà¹Ø²¡¶¾£¨AAV£©ÔØÌåµÄ»ùÒòÖÎÁÆÒ©Î£¬£¬£¬£¬ÊÊÓÃÓÚÖÎÁÆ6ÔÂÁä¼°ÒÔÉÏ5qÐͼ¹ËèÐÔ¼¡Î®ËõÖ¢£¨SMA£©»¼Õß¡£¡£¡£¡£¡£¡£

2. ¿ËÈÕ£¬£¬£¬£¬£¬ÉîÛÚ°ÂÀñÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾»ñϤ£¬£¬£¬£¬£¬NMPAÕýʽÅú×¼Æä×ÔÖ÷Ñз¢µÄOLP-210Ƭ¿ªÕ¹ÁÙ´²ÊÔÑ飬£¬£¬£¬£¬Ë³Ó¦Ö¢Îª·ÊÅÖ»ò³¬ÖسÉÈ˵ÄÌåÖØ¹ÜÀí¡£¡£¡£¡£¡£¡£OLP-210ƬÊǰÂÀñÉúÎ↑·¢µÄÒ»ÖÖÓÃÓÚÌåÖØ¹ÜÀíµÄ¿Ú·þGLP-1¶àëÄÒ©Îï¡£¡£¡£¡£¡£¡£

3. ¿ËÈÕ£¬£¬£¬£¬£¬NMPA¹ÙÍøÏÔʾ£¬£¬£¬£¬£¬ÖÐɽ»ð¾æ¸ßÐÂÇøÆóÒµ¹ã¶«ÍòÌ©¿Æ´´Ò©ÒµÓÐÏÞ¹«Ë¾°´3Àà×¢²áÉ걨µÄ±½»ÇËá°±ÂÈµØÆ½¿Ú±ÀƬ»ñÅúÉÏÊУ¬£¬£¬£¬£¬³ÉΪº£ÄڸüÁÐ͵ÄÊ×·ÂÇÒÊ×¼Òͨ¹ýÒ»ÖÂÐÔÆÀ¼ÛµÄ²úÆ·£¬£¬£¬£¬£¬¿ÉÓÃÓÚ¶ùͯ¡¢ÀÏÈËÓÃҩ˳Ӧ֢µÄ¿Ú·þ½µÑ¹Ò©¡£¡£¡£¡£¡£¡£

4. ¿ËÈÕ£¬£¬£¬£¬£¬ÓÉÔÆÄÏ·½Ê¢ÈÚºÍÒ©ÒµÓÐÏÞ¹«Ë¾ÓëÔÆÄÏÖÐÒ½Ò©´óѧÅäºÏÉ걨µÄÖÐÒ©1.1ÀàÐÂÒ©ÏãÜ˽âÈÈ¿ÅÁ£»£»£»£»£» £»ñ¹ú¼ÒÒ©Æ·¼àÊÓ¹ÜÀí¾ÖÒ©ÎïÁÙ´²ÊÔÑéÅú×¼£¬£¬£¬£¬£¬ÓÃÓÚÖÎÁƳÉÈËÊ¢ÐÐÐÔÉË·çʪÈÈÓô±íÖ¤¡£¡£¡£¡£¡£¡£

ͶÈÚÒ©ÊÂ

1. 7ÔÂ14ÈÕ£¬£¬£¬£¬£¬Âó¼ÃÉúÎïÌá½»¸Û¹ÉIPOÉêÇ룬£¬£¬£¬£¬Öнð¹«Ë¾µ£µ±¶À¼Ò±£¼ö¡£¡£¡£¡£¡£¡£Âó¼ÃÉúÎィÉèÓÚ2016Ä꣬£¬£¬£¬£¬ÖÂÁ¦ÓÚ·¢Ã÷¡¢¿ª·¢¼°ÉÌÒµ»¯Á¢ÒìÉúÎïÖÆ¼Á£¬£¬£¬£¬£¬ÒÔÖª×ã¹ýÃôÐÔ¼°×ÔÉíÃâÒß¼²²¡ÒÔ¼°ÆäËûÑ×Ö¢ÐÔ¼°ÃâÒßÐÔ¼²²¡ÖÐδ֪×ãµÄÒ½ÁÆÐèÇ󡣡£¡£¡£¡£¡£

¿Æ¼¼Ò©ÑÐ

1. 7ÔÂ14ÈÕ£¬£¬£¬£¬£¬Õã½­´óѧҽѧԺÁ¥ÊôµÚÒ»Ò½ÔºËï½Ü¡¢»ÆºÓÍŶÓÓÚÔÚNature Biomedical Engineering ÔÓÖ¾½ÒÏþÁËÒ»ÏîÁ¢ÒìÑо¿¡£¡£¡£¡£¡£¡£¸ÃÍŶÓÉè¼ÆÁËÒ»ÖÖ»ùÓÚ˫˳·´×ÓÔØÌåµÄ»ùÒò¹¤³Ì²ßÂÔ£¬£¬£¬£¬£¬Ë¢Ð CAR-T ϸ°û£¬£¬£¬£¬£¬Ê¹ÆäÔÚ±í´ï°ÐÏòÖ×Áö¿¹Ô­µÄǶºÏ¿¹Ô­ÊÜÌ壨CAR£©µÄͬʱ£¬£¬£¬£¬£¬Äܹ»Ò»Á¬ÉøÍ¸Ë«ÌØÒìÐÔ NK ϸ°ûÏÎ½ÓÆ÷£¨BiKE£©¡£¡£¡£¡£¡£¡£ÕâÖÖÉè¼ÆÖ¼ÔÚЭͬ¼¤»î»¼Õß×ÔÉíµÄ×ÔȻɱÉË£¨NK£©Ï¸°û£¬£¬£¬£¬£¬´Ó¶øÏÔÖøÔöÇ¿ÕûÌ忹Ö×ÁöЧ¹û¡£¡£¡£¡£¡£¡£

[1]Ya Fan et al. Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses. Nature Biomedical Engineering£¨2025£©https://www.nature.com/articles/s41551-025-01450-4

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿